GLP-1s and Pregnancy: What the Data Actually Shows

The question that brought you here

Maybe you're planning ahead and want to know when to stop. Or maybe you already have a positive test in your hand and your heart racing. GLP-1 treatment for weight loss should be stopped when pregnancy is recognized. Contact your prescriber and obstetric clinician promptly; if the medicine treats diabetes or another condition, arrange a pregnancy-appropriate treatment plan urgently. Early-exposure studies have not found a clear increase in major birth defects, but they cannot establish safety for an individual pregnancy^1,3,5.

Why the label says stop

The Wegovy label says weight loss offers no benefit during pregnancy and may cause fetal harm, so treatment for weight reduction should be discontinued when pregnancy is recognized¹. Animal studies found fetal growth and developmental problems; human evidence remains limited^1,2. The indication matters: Wegovy's label uses benefit-risk language for MASH (a liver disease), and Ozempic's label uses benefit-risk language for diabetes rather than the same weight-loss stop instruction. Poorly controlled diabetes itself carries pregnancy risks, so a change needs a treatment plan^1,5. Both semaglutide labels advise stopping at least two months before a planned pregnancy because of the drug's long half-life^1,5.

What actually calms things down

A 2026 meta-analysis combined six observational studies, reporting 43,577 women exposed around conception. It found no statistically significant increase in major congenital malformations compared with unexposed pregnancies. The authors caution that this is not proof of safety³. A separate 2026 review found early-exposure results broadly reassuring but heterogeneous; evidence for continued use throughout pregnancy remains limited⁴. These findings support a calm discussion after accidental exposure, not a guarantee about an individual baby. Different studies examine different exposure windows and comparison groups, so their results cannot simply be extended to every drug, dose or stage of pregnancy.

If you're already pregnant

1. 1.Check the medication and why you take it. Wegovy used for weight loss should be stopped when pregnancy is recognized. If you take Ozempic for diabetes or Wegovy for another indication, contact your prescriber urgently to review treatment and alternatives^1,5.
2. 2.Call your OB soon. Tell her exactly what you were taking and when your last dose was. This isn't a new conversation for her.
3. 3.Don't panic. The pooled data don't show a significantly higher risk from an early accidental exposure^3,4.
4. 4.Start your normal prenatal care — folate, your first visit, whatever your OB recommends. The goal shifts from weight loss to a healthy pregnancy.

If you're still planning

If pregnancy hasn't happened yet, the calmer version is the planned one: contraception while you're still on the medication, a deliberate stop per your specific drug's label, and then trying. Our guide to GLP-1s and fertility covers the full washout window and what happens after you stop, and if PCOS is part of your story, can GLP-1 help PCOS? explains why ovulation sometimes comes back faster than expected.

How much to trust each claim

Weight-loss treatment and treatment of an underlying disease need different pregnancy decisions. The weight-loss stop instruction is on the Wegovy label; Ozempic for diabetes requires a prompt benefit-risk and replacement-treatment discussion^1,5. Observational studies of early exposure have not found a clear increase in major birth defects, which is reassuring, but they cannot tell an individual family that an exposure caused no harm or establish safety for continued use throughout pregnancy^3,4.